Former Companion at Choate Corridor & Stewart Brings Important Expertise with Formation, Construction and Financing of Life Sciences Firms
BOSTON–(BUSINESS WIRE)–August 28, 2017–
Xontogeny, LLC, a life sciences accelerator working firm centered on the early development of prescribed drugs and different applied sciences, right now announced that Fred Callori has been appointed as Senior Vice President of Company Growth. Mr. Callori joins Xontogeny after serving as a associate within the Life Sciences and rising firms practices of Choate Hall & Stewart LLP, a Boston legislation agency ranked among the many top most lively legislation companies worldwide for personal fairness and enterprise capital offers.
This Good Information Launch options multimedia. View the complete launch right here: http://www.businesswire.com/news/home/20170828005060/en/
Fred Callori (Photograph: Enterprise Wire)
“Fred is an ideal first senior-level hire for us, to ensure that Xontogeny establishes the optimal relationship and structure with entrepreneurs and portfolio companies from the very first interactions,” stated Chris Garabedian, Founder, Chairman and CEO of Xontogeny. “Fred’s tremendous experience advising many of the leading firms that are involved in the formation, financing, and management of startup and emerging growth companies in the life sciences sector, will be an asset to Xontogeny and to the companies in our portfolio.”
“I’m excited to join Xontogeny and reinforce its unique model of supporting early research and development across its portfolio of companies,” stated Mr. Callori. “The Xontogeny approach provides a cost-efficient alternative to developing drugs and technology from preclinical through clinical proof of concept, while working toward a goal of significantly increasing success rates of drug development and positive clinical outcomes.”
Throughout his 20 years at Choate, Mr. Callori suggested purchasers on the formation, construction, financing and general company development of early stage and rising life science firms, together with representing main enterprise capital and public fairness funding companies centered on this sector. As well as, Mr. Callori, who’s listed in The Legal 500 for middle-market M&A, has represented underwriters in public choices with SEC-related issues and quite a few public and non-public securities transactions. His major apply areas embrace life sciences, enterprise & expertise, capital markets, public firms, company governance and personal fairness. Mr. Callori obtained his J.D. from Boston College in 1994 and likewise holds an undergraduate diploma from Binghamton College.
“We’ve had the privilege of working with Xontogeny and its founder Chris Garabedian as clients during the past year and we can’t think of anyone better to help them in pursuit of their mission than our former partner Fred Callori,” stated Invoice Gelnaw, Co-Managing Companion, Choate. “Fred has made significant contributions to Choate and our clients for 20 years. We’re incredibly excited for Fred and wish him great success in this next chapter of his career.”
As Senior VP of Company Growth, Mr. Callori will assist Xontogeny’s strategic and operational aims, together with offering general company governance, serving as a liaison to portfolio firms, managing investor relations, and shaping Xontogeny’s strategic plan to drive success throughout its portfolio.
Over the following yr, Xontogeny expects to launch a number of firms to construct out its portfolio throughout a number of therapeutic areas. To remain knowledgeable on Xontogeny news, visit the corporate’s web site at www.xontogeny.com.
Xontogeny was based by business veteran Chris Garabedian and launched with a $25M Collection A spherical in Could 2017. The corporate, primarily based in Boston, MA, seeks to assist and speed up the development of life science applied sciences from early development by scientific proof-of-concept. Xontogeny gives entrepreneurs with the management, strategic steering and operational assist needed to extend the chance of success in early drug and expertise development. By means of a differentiated method, the Xontogeny workforce companions with the founding scientists and entrepreneurs of recent ventures to assist their vision whereas permitting a extra environment friendly development mannequin to learn firm founders and early fairness holders. For extra data, please visit www.xontogeny.com or contact Xontogeny by emailing [email protected].